600518 康美药业
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产2,757,817-1.76%2,807,2212,768,3812,243,0223,380,621
固定资产3,370,629-2.19%3,446,2043,731,3434,190,8477,973,124
在建工程172,641-18.01%210,564215,502263,6461,629,980
无形资产469,981-4.29%491,023529,795579,7301,308,504
商誉106,3510.00%106,351106,351106,35136,909
其他非流动资产385,635-5.77%409,266433,217385,869455,868
7,263,053-2.78%7,470,6297,784,5897,769,46614,785,006

流动资产
货币资金794,969-24.76%1,056,6071,507,3972,418,606552,338
应收账款2,174,4627.16%2,029,1391,964,9551,356,6962,405,292
存货2,886,6529.19%2,643,7492,750,6933,194,9065,708,840
其他流动资产1,137,8685.33%1,080,2561,160,9451,314,5859,874,655
6,993,9512.70%6,809,7507,383,9908,284,79318,541,125

流动负债
短期借款23,410-10.43%26,13725,61915,1742,314,767
应付票据89,96375.26%51,33030,40000
应付帐款2,433,38410.35%2,205,0612,533,0502,015,0503,762,118
其他流动负债2,155,350-10.10%2,397,4932,852,4432,916,34917,208,796
4,702,1080.47%4,680,0215,441,5124,946,57223,285,681
流动资产净值2,291,8447.61%2,129,7291,942,4793,338,221(4,744,556)
资产总额减流动负债9,554,897-0.47%9,600,3589,727,06811,107,68710,040,450

非流动负债
长期借款0--00010,043,909
应付债券0--0009,371,335
其他非流动负债2,455,256-2.57%2,519,9062,743,2311,139,2131,034,828
2,455,256-2.57%2,519,9062,743,2311,139,21320,450,072

总权益
    实收股本13,863,8670.00%13,863,86713,863,86713,863,8674,973,862
    储备项目(6,799,978)-0.24%(6,816,308)(6,915,460)(3,937,312)(15,509,959)
股东权益7,063,8890.23%7,047,5596,948,4079,926,555(10,536,097)
非控股权益35,7528.70%32,89235,43041,919126,475